Personalized Therapies in Inflammatory Complex Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Inflammatory DiseaseAutoimmune Diseases
Interventions
DRUG

Kineret

100 mg, once/day sc 6 months

DRUG

Humira

40 mg/15 days sc 6 months

DRUG

Stelara

45 mg/12 weeks sc, 6 months

DRUG

Cosentyx

300mg sc every week for 1 month, then 300 mg/month sc for 5 months

DRUG

Roactemra

480 mg/perf/4 weeks 6 months

DRUG

Rituximab

2 sessions of 1000 mg at inclusion and 15 days after inclusion

Trial Locations (1)

75014

RECRUITING

Hôpital Cochin, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER